Race Receives Cardioprotection Ethics Trial Approval

<p class="typography-body-regular">Race Receives Human Ethics Approval for Observational Cardioprotection Breast Cancer Trial:</p>

<p class="typography-body-regular"><br></p>

<p class="typography-body-regular">- Human ethics approval received for the initial observational stage of a plannedinterventional Phase 1/2b cardioprotection clinical program using Zantrene</p>

<p class="typography-body-regular"><br></p>

<p class="typography-body-regular">- Research institutional governance submission is expected soon and will enable enrolment of the first study patient</p>

<p class="typography-body-regular"><br></p>

<p class="typography-body-regular">- This &nbsp;&nbsp;observation &nbsp;&nbsp;trial &nbsp;&nbsp;is &nbsp;&nbsp;the first &nbsp;&nbsp;step &nbsp;&nbsp;in &nbsp;&nbsp;advancing &nbsp;&nbsp;the &nbsp;&nbsp;cardioprotection opportunity for Zantrene in the clinic.</p>